Oncotarget
Loss of obscurins downregulates RhoA signaling in attached MCF10A cells. See Perry et al.
BRAF-mutant hematopoietic malignancies |
https://doi.org/10.18632/oncotarget.2448 Omar Abdel-Wahab, and Christopher Y. Park |
7980-7981 |
PDF | How to cite | Order a Reprint |
The reverse Warburg effect in osteosarcoma |
https://doi.org/10.18632/oncotarget.2352 Federica Sotgia, Ubaldo E. Martinez-Outschoorn, and Michael P. Lisanti |
7982-7983 |
PDF | How to cite | Order a Reprint |
‘Sex’ in the cancer cell |
https://doi.org/10.18632/oncotarget.2355 Inam J. Lafta, Helen E. Bryant, and Alastair S. H. Goldman |
7984-7985 |
PDF | How to cite | Order a Reprint |
Oncogene addiction: resetting the safety switch? |
https://doi.org/10.18632/oncotarget.2474 Yulin Li, Peter S. Choi, and Dean W. Felsher |
7986-7987 |
Abstract | PDF | How to cite | Order a Reprint |
Screening for E3-Ubiquitin ligase inhibitors: challenges and opportunities |
https://doi.org/10.18632/oncotarget.2431 Vivien Landré, Barak Rotblat, Sonia Melino, Francesca Bernassola, and Gerry Melino |
7988-8013 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
The IGF signalling pathway in Wilms tumours - A report from the ENCCA Renal Tumours Biology-driven drug development workshop |
https://doi.org/10.18632/oncotarget.2485 Mariana Maschietto, Jocelyn Charlton, Daniela Perotti, Paolo Radice, James I. Geller, Kathy Pritchard-Jones, and Mark Weeks |
8014-8026 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer |
https://doi.org/10.18632/oncotarget.2469 Ehsan Malek, Sajjeev Jagannathan, and James J. Driscoll |
8027-8038 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Regulatory roles of LINE-1-encoded reverse transcriptase in cancer onset and progression |
https://doi.org/10.18632/oncotarget.2504 Ilaria Sciamanna, Alberto Gualtieri, Pier Vincenzo Piazza, and Corrado Spadafora |
8039-8051 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide |
https://doi.org/10.18632/oncotarget.2408 Richard E. Kast, Georg Karpel-Massler, and Marc-Eric Halatsch |
8052-8082 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas |
https://doi.org/10.18632/oncotarget.2342 Jane B. Cryan, Sam Haidar, Lori A. Ramkissoon, Wenya Linda Bi, David S. Knoff, Nikolaus Schultz, Malak Abedalthagafi, Loreal Brown, Patrick Y. Wen, David A. Reardon, Ian F. Dunn, Rebecca D. Folkerth, Sandro Santagata, Neal I. Lindeman, Azra H. Ligon, Rameen Beroukhim, Jason L. Hornick, Brian M. Alexander, Keith L. Ligon, and Shakti H. Ramkissoon |
8083-8092 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Anti-cancer potency of tasquinimod is enhanced via albumin-binding facilitating increased uptake in the tumor microenvironment |
https://doi.org/10.18632/oncotarget.2378 John T. Isaacs, Susan L. Dalrymple, Marc D. Rosen, Hans Hammers, Anders Olsson, and Tomas Leanderson |
8093-8106 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
TAp73 promotes cell survival upon genotoxic stress by inhibiting p53 activity |
https://doi.org/10.18632/oncotarget.2440 Dongshi Chen, Lihua Ming, Fangdong Zou, Ye Peng, Bennett Van Houten, Jian Yu, and Lin Zhang |
8107-8122 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Identification of a DNA methylation signature to predict disease-free survival in locally advanced rectal cancer |
https://doi.org/10.18632/oncotarget.2347 Jochen Gaedcke, Andreas Leha, Rainer Claus, Dieter Weichenhan, Klaus Jung, Julia Kitz, Marian Grade, Hendrik A. Wolff, Peter Jo, Jérôme Doyen, Jean-Pierre Gérard, Steven A. Johnsen, Christoph Plass, Tim Beißbarth, and Michael Ghadimi |
8123-8135 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors |
https://doi.org/10.18632/oncotarget.2357 Hatem H. Soliman, Erica Jackson, Tony Neuger, Claire E. Dees, Donald R. Harvey, Hyo Han, Roohi Ismail-Khan, Susan Minton, Nicholas N. Vahanian, Charles Link, Daniel M. Sullivan, and Scott Antonia |
8136-8146 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients |
https://doi.org/10.18632/oncotarget.2385 Irène Baccelli, Albrecht Stenzinger, Vanessa Vogel, Berit Maria Pfitzner, Corinna Klein, Markus Wallwiener, Martina Scharpff, Massimo Saini, Tim Holland-Letz, Hans-Peter Sinn, Andreas Schneeweiss, Carsten Denkert, Wilko Weichert, and Andreas Trumpp |
8147-8160 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors |
https://doi.org/10.18632/oncotarget.2415 Gideon M. Blumenthal, Joell J. Gills, Marc S. Ballas, Wendy B. Bernstein, Takefumi Komiya, Roopa Dechowdhury, Betsy Morrow, Hyejeong Root, Guinevere Chun, Cynthia Helsabeck, Seth M. Steinberg, Jaclyn LoPiccolo, Shigeru Kawabata, Erin R. Gardner, William D. Figg, and Phillip A. Dennis |
8161-8172 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer |
https://doi.org/10.18632/oncotarget.2303 Victor M. Campa, Eder Baltziskueta, Nora Bengoa-Vergniory, Irantzu Gorroño-Etxebarria, Radosław Wesołowski, Jonathan Waxman, and Robert M. Kypta |
8173-8187 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells |
https://doi.org/10.18632/oncotarget.2340 Hao Yang, Hui Hui, Qian Wang, Hui Li, Kai Zhao, Yuxin Zhou, Yu Zhu, Xiaotang Wang, Qidong You, Qinglong Guo, and Na Lu |
8188-8201 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers |
https://doi.org/10.18632/oncotarget.1159 Shruti Desai, Minming Ding, Bin Wang, Zhimin Lu, Qi Zhao, Kenna Shaw, W K Alfred Yung, John N Weinstein, Ming Tan, and Jun Yao |
8202-8210 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells |
https://doi.org/10.18632/oncotarget.1788 Sandrine Bouchet, Ruoping Tang, Fanny Fava, Ollivier Legrand, and Brigitte Bauvois |
8211-8222 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649) |
https://doi.org/10.18632/oncotarget.1910 Stian Knappskog, Liv B. Gansmo, Khadizha Dibirova, Andres Metspalu, Cezary Cybulski, Paolo Peterlongo, Lauri Aaltonen, Lars Vatten, Pål Romundstad, Kristian Hveem, Peter Devilee, Gareth D. Evans, Dongxin Lin, Guy Van Camp, Vangelis G. Manolopoulos, Ana Osorio, Lili Milani, Tayfun Ozcelik, Pierre Zalloua, Francis Mouzaya, Elena Bliznetz, Elena Balanovska, Elvira Pocheshkova, Vaidutis Kučinskas, Lubov Atramentova, Pagbajabyn Nymadawa, Konstantin Titov, Maria Lavryashina, Yuldash Yusupov, Natalia Bogdanova, Sergey Koshel, Jorge Zamora, David C. Wedge, Deborah Charlesworth, Thilo Dörk, Oleg Balanovsky, and Per E. Lønning |
8223-8234 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice |
https://doi.org/10.18632/oncotarget.1632 Sandra Dupouy, Van Kien Doan, Zherui Wu, Najat Mourra, Olivier De Wever, Frédérique Penault Llorca, Anne Cayre, Amal Kouchkar, Anne Gompel, and Patricia Forgez |
8235-8251 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib |
https://doi.org/10.18632/oncotarget.1633 Mohamad Younes, Zherui Wu, Sandra Dupouy, Audrey Mansuet Lupo, Najat Mourra, Takashi Takahashi, Jean-Francois Flejou, Jean Trédaniel, Jean François Régnard, Diane Damotte, Marco Alifano, and Patricia Forgez |
8252-8269 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved |
https://doi.org/10.18632/oncotarget.2013 Maria Grazia Vizioli, Joana Santos, Silvana Pilotti, Mara Mazzoni, Maria Chiara Anania, Claudia Miranda, Sonia Pagliardini, Marco A. Pierotti, Jesus Gil, and Angela Greco |
8270-8283 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease |
https://doi.org/10.18632/oncotarget.2058 Antonio Garcia-Gomez, Javier De Las Rivas, Enrique M. Ocio, Elena Díaz-Rodríguez, Juan C. Montero, Montserrat Martín, Juan F. Blanco, Fermín M. Sanchez-Guijo, Atanasio Pandiella, Jesús F. San Miguel, and Mercedes Garayoa |
8284-8305 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells |
https://doi.org/10.18632/oncotarget.2059 Bruna Corominas-Faja, Elisabet Cuyàs, Juan Gumuzio, Joaquim Bosch-Barrera, Olatz Leis, Ángel G. Martin, and Javier A. Menendez |
8306-8316 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression |
https://doi.org/10.18632/oncotarget.2135 Guangchao Li, Likun Zhao, Wei Li, Kexing Fan, Weizhu Qian, Sheng Hou, Hao Wang, Jianxin Dai, Huafeng Wei, and Yajun Guo |
8317-8329 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway |
https://doi.org/10.18632/oncotarget.2212 Ning Zhang, Eagle S. H. Chu, Jingwan Zhang, Xiaoxing Li, Qiaoyi Liang, Jie Chen, Minhu Chen, Narci Teoh, Geoffrey Farrell, Joseph J. Y. Sung, and Jun Yu |
8330-8340 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs |
https://doi.org/10.18632/oncotarget.2202 Francesco Esposito, Marco De Martino, Maria Grazia Petti, Floriana Forzati, Mara Tornincasa, Antonella Federico, Claudio Arra, Giovanna Maria Pierantoni, and Alfredo Fusco |
8341-8354 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
ARID3B increases ovarian tumor burden and is associated with a cancer stem cell gene signature |
https://doi.org/10.18632/oncotarget.2247 Lynn Roy, Serene J. Samyesudhas, Martin Carrasco, Jun Li, Stancy Joseph, Richard Dahl, and Karen D. Cowden Dahl |
8355-8366 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Oncogene-triggered suppression of DNA repair leads to DNA instability in cancer |
https://doi.org/10.18632/oncotarget.2259 Julia A. Yaglom, Christopher McFarland, Leonid Mirny, and Michael Y. Sherman |
8367-8378 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism |
https://doi.org/10.18632/oncotarget.2292 Ahmed Waraky, Karen Akopyan, Vendela Parrow, Thomas Strömberg, Magnus Axelson, Lars Abrahmsén, Arne Lindqvist, Olle Larsson, and Eiman Aleem |
8379-8392 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells |
https://doi.org/10.18632/oncotarget.2298 Yan Ding, Ai Qing Yu, Cheng Lin Li, Juan Fang, Yi Zeng, and Dong Sheng Li |
8393-8401 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Therapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model |
https://doi.org/10.18632/oncotarget.2311 Young-Eun Kim, Sanghoon Kwon, Guang Wu, Dongbum Kim, Byoung Kwon Park, Jeong-A Park, Kyung-Chan Choi, Doo-Sik Kim, Hyung-Joo Kwon, and Younghee Lee |
8402-8415 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer |
https://doi.org/10.18632/oncotarget.2314 Zhiqiang Han, Xiaoli Wang, Liang Ma, Lijuan Chen, Min Xiao, Liang Huang, Yang Cao, Jian Bai, Ding Ma, Jianfeng Zhou, and Zhenya Hong |
8416-8428 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.2316 Chong Li, Ji Wang, Hong Zhang, Mingao Zhu, Feifei Chen, Yufeng Hu, Hudan Liu, and Hong Zhu |
8429-8441 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Regulatory effects of a Mnk2-eIF4E feedback loop during mTORC1 targeting of human medulloblastoma cells |
https://doi.org/10.18632/oncotarget.2319 Frank Eckerdt, Elspeth Beauchamp, Jonathan Bell, Asneha Iqbal, Bing Su, Rikiro Fukunaga, Rishi R. Lulla, Stewart Goldman, and Leonidas C. Platanias |
8442-8451 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory Complex-I activity via Bcl-2 family proteins |
https://doi.org/10.18632/oncotarget.2320 Eun Mi Kim, Jong Kuk Park, Sang-Gu Hwang, Wun-Jae Kim, Zheng-Gang Liu, Sang Won Kang, and Hong-Duck Um |
8452-8465 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation |
https://doi.org/10.18632/oncotarget.2327 Youlin Yao, Chao Li, Xiaoyan Zhou, Yu Zhang, Yilu Lu, Jianhui Chen, Xulei Zheng, Dachang Tao, Yunqiang Liu, and Yongxin Ma |
8466-8477 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway |
https://doi.org/10.18632/oncotarget.2328 Jiabei Wang, Dalong Yin, Changming Xie, Tongsen Zheng, Yingjian Liang, Xuehui Hong, Zhaoyang Lu, Xuan Song, Ruipeng Song, Haiyan Yang, Boshi Sun, Nishant Bhatta, Xianzhi Meng, Shangha Pan, Hongchi Jiang, and Lianxin Liu |
8478-8491 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer |
https://doi.org/10.18632/oncotarget.2329 Anna Lena Ress, Verena Stiegelbauer, Daniela Schwarzenbacher, Alexander Deutsch, Samantha Perakis, Hui Ling, Cristina Ivan, George Adrian Calin, Beate Rinner, Armin Gerger, and Martin Pichler |
8492-8502 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets |
https://doi.org/10.18632/oncotarget.2330 Kumar Saurabh, Michael T. Scherzer, Parag P. Shah, Alice S. Mims, William W. Lockwood, Andrew S. Kraft, and Levi J. Beverly |
8503-8514 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Efficient lytic induction of kaposi’s sarcoma-associated herpesvirus (KSHV) by the anthracyclines |
https://doi.org/10.18632/oncotarget.2335 Hyunju Kang, Jaehyung Song, Kwangman Choi, Hyeongki Kim, Miri Choi, So-Young Lee, Chonsaeng Kim, Sang Jun Lee, Moon Jung Song, Hyojeung Kang, Sung Hoon Back, Sang-Bae Han, and Sungchan Cho |
8515-8527 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives |
https://doi.org/10.18632/oncotarget.2336 Guoying Zhang, Xinshan Ye, Dexin Ji, Huarong Zhang, Fujia Sun, Chunqing Shang, Ying Zhang, Erxi Wu, Fengfei Wang, Fei Wu, Huihui Tian, Xin Liu, Linlin Chen, Kun Liu, Hanchen Liu, Yishan Wang, Wenhua Zhang, Yukun Guan, Qinwen Wang, Xiaohang Zhao, and Xiaochun Wan |
8528-8543 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors |
https://doi.org/10.18632/oncotarget.2337 Burhan Hassan, Argun Akcakanat, Takafumi Sangai, Kurt W. Evans, Farrell Adkins, Agda Karina Eterovic, Hao Zhao, Ken Chen, Huiqin Chen, Kim-Anh Do, Shelly M. Xie, Ashley M. Holder, Aung Naing, Gordon B. Mills, and Funda Meric-Bernstam |
8544-8557 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells |
https://doi.org/10.18632/oncotarget.2338 Nicole A. Perry, Michele I. Vitolo, Stuart S. Martin, and Aikaterini Kontrogianni-Konstantopoulos |
8558-8568 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma |
https://doi.org/10.18632/oncotarget.2322 Jian-Jun Xie, Yang-Min Xie, Bo Chen, Feng Pan, Jin-Cheng Guo, Qing Zhao, Jin-Hui Shen, Zhi-Yong Wu, Jian-Yi Wu, Li-Yan Xu, and En-Min Li |
8569-8582 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma |
https://doi.org/10.18632/oncotarget.2323 Shih-Hsin Chiu, Chung-Chun Wu, Chih-Yeu Fang, Shu-Ling Yu, Hui-Yu Hsu, Yen-Hung Chow, and Jen-Yang Chen |
8583-8601 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma |
https://doi.org/10.18632/oncotarget.2343 Yona Goldshmit, Sari Schokoroy Trangle, Yoel Kloog, and Ronit Pinkas-Kramarski |
8602-8613 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Selective targeting of liver cancer with the endothelial marker CD146 |
https://doi.org/10.18632/oncotarget.2345 Stefan Thomann, Thomas Longerich, Alexandr V. Bazhin, Walter Mier, Peter Schemmer, and Eduard Ryschich |
8614-8624 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas |
https://doi.org/10.18632/oncotarget.2349 Haiyang Guo, Xiyu Zhang, Ruifen Dong, Xiaolin Liu, Yinuo Li, Shan Lu, Limei Xu, Yuqiong Wang, Xiyao Wang, Dong Hou, Jian-Jun Wei, Changshun Shao, and Zhaojian Liu |
8625-8636 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Selective JAK2/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem/progenitor cells |
https://doi.org/10.18632/oncotarget.2353 Hanyang Lin, Min Chen, Katharina Rothe, Matthew V. Lorenzi, Adrian Woolfson, and Xiaoyan Jiang |
8637-8650 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease |
https://doi.org/10.18632/oncotarget.2354 Heidi N. Hilton, Tram B. Doan, J. Dinny Graham, Samantha R. Oakes, Audrey Silvestri, Nicole Santucci, Silke Kantimm, Lily I. Huschtscha, Christopher J. Ormandy, John W. Funder, Evan R. Simpson, Elizabeth S. Kuczek, Peter J. Leedman, Wayne D. Tilley, Peter J. Fuller, George E. O. Muscat, and Christine L. Clarke |
8651-8664 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell |
https://doi.org/10.18632/oncotarget.2356 Mayuko Nishi, Hidenori Akutsu, Ayumi Kudoh, Hirokazu Kimura, Naoki Yamamoto, Akihiro Umezawa, Sam W. Lee, and Akihide Ryo |
8665-8680 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer |
https://doi.org/10.18632/oncotarget.2365 Antje Neeb, Simon Hefele, Stefanie Bormann, Walther Parson, Fabian Adams, Philipp Wolf, Arkadiusz Miernik, Martin Schoenthaler, Malte Kroenig, Konrad Wilhelm, Wolfgang Schultze-Seemann, Sigrun Nestel, Georg Schaefer, Huajie Bu, Helmut Klocker, Irina Nazarenko, and Andrew C. B. Cato |
8681-8689 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Intracellular and extracellular domains of protein tyrosine phosphatase PTPRZ-B differentially regulate glioma cell growth and motility |
https://doi.org/10.18632/oncotarget.2366 Annika M. Bourgonje, Anna C. Navis, Jan T.G. Schepens, Kiek Verrijp, Liesbeth Hovestad, Riet Hilhorst, Sheila Harroch, Pieter Wesseling, William P.J. Leenders, and Wiljan J.A.J. Hendriks |
8690-8702 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors |
https://doi.org/10.18632/oncotarget.2367 Ayesha B. Alvero, Michele K. Montagna, Natalia J. Sumi, Won Duk Joo, Emma Graham, and Gil Mor |
8703-8715 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
IL-6-stimulated CD11b+ CD14+ HLA-DR− myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus |
https://doi.org/10.18632/oncotarget.2368 Miao-Fen Chen, Feng-Che Kuan, Tzu-Chen Yen, Ming-Shian Lu, Paul-Yang Lin, Yi-Hsiu Chung, Wen-Cheng Chen, and Kuan-Der Lee |
8716-8728 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Selective methioninase-induced trap of cancer cells in S/G2 phase visualized by FUCCI imaging confers chemosensitivity |
https://doi.org/10.18632/oncotarget.2369 Shuya Yano, Shukuan Li, Qinghong Han, Yuying Tan, Michael Bouvet, Toshiyoshi Fujiwara, and Robert M. Hoffman |
8729-8736 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma |
https://doi.org/10.18632/oncotarget.2372 Nathan F. Moore, Anna M. Azarova, Namrata Bhatnagar, Kenneth N. Ross, Lauren E. Drake, Stacey Frumm, Qinsong S. Liu, Amanda L. Christie, Takaomi Sanda, Louis Chesler, Andrew L. Kung, Nathanael S. Gray, Kimberly Stegmaier, and Rani E. George |
8737-8749 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer |
https://doi.org/10.18632/oncotarget.2373 Zachary C. Dobbin, Ashwini A. Katre, Adam D. Steg, Britt K. Erickson, Monjri M. Shah, Ronald D. Alvarez, Michael G. Conner, David Schneider, Dongquan Chen, and Charles N. Landen |
8750-8764 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification |
https://doi.org/10.18632/oncotarget.2364 Yun Sun Park, Jeong-Woo Kang, Dong Hun Lee, Man Sub Kim, Yesol Bak, Young Yang, Hee Gu Lee, JinTae Hong, and Do-Young Yoon |
8765-8777 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
p-21 activated kinase 4 promotes proliferation and survival of pancreatic cancer cells through AKT- and ERK-dependent activation of NF-κB pathway |
https://doi.org/10.18632/oncotarget.2398 Nikhil Tyagi, Arun Bhardwaj, Ajay P. Singh, Steven McClellan, James E. Carter, and Seema Singh |
8778-8789 |
Abstract | PDF | HTML | How to cite | Order a Reprint |
IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies |
https://doi.org/10.18632/oncotarget.2405 Phillipe Loher, Eric R. Londin, and Isidore Rigoutsos |
8790-8802 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in Head and Neck cancer |
https://doi.org/10.18632/oncotarget.2492 Daniel J. Sharpe, Katy S. Orr, Michael Moran, Sharon J. White, Stephen McQuaid, Terence R. Lappin, Alexander Thompson, and Jacqueline A. James |
8803-8815 |
Abstract | PDF | HTML | Supplementary Information | How to cite | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC